FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to new anxiolytic agents, namely N-substituted 4-(1-hydroxy-1-methyl-2-aminoethyl)benzoic acids of the general formula (1), their pharmaceutically acceptable salts. The invention also relates to a method for obtaining compounds, consisting in the implementation of three stages.
EFFECT: compounds of the general formula (1) having a pronounced anxiolytic effect with low toxicity with no sedative effect and excitatory effect on the central nervous system.
where R=H, -CnH2n+1 (n=1-6),
(n=1-4),
2 cl, 9 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
4-(1-HYDROXY-1-METHYL-2-MORPHOLINOETHYL)BENZOIC AND 4-(1-HYDROXY-2-MORPHOLINOCYCLOHEXYL)BENZOIC ACIDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS, POSSESSING ANXIOLYTIC ACTIVITY, AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2505536C1 |
1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2655170C2 |
CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID-DEHYDROGENASE 1 | 2009 |
|
RU2531272C2 |
BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEREOF | 1998 |
|
RU2178787C2 |
2-SUBSTITUTED-1,2,4,5-TETRAHYDRO-3H-PYRROLO[1,2-a][1,4]DIAZEPIN-3-ONES | 2011 |
|
RU2472795C1 |
4-HYDROXY-N-(2-CARBOXYPHENYL)-1-METHYL-2,2-DIOXO-1H-2λ,1-BENZOTHIAZINE-3-CARBOXAMIDE, DEMONSTRATING DIURETIC ACTIVITY | 2013 |
|
RU2535997C1 |
ANTAGONISTS OF SPHINGONSINE-1-PHOSPHATE (S1P) RECEPTOR AND METHODS OF THEREOF APPLICATION | 2009 |
|
RU2505527C2 |
1-BIPHENYLMETHYL IMIDAZOLE, PHARMACEUTICALLY ACCEPTABLE SALTS OR ETHERS THEREOF, AND METHOD OF PREPARATION THEREOF | 1992 |
|
RU2092481C1 |
FURO[3,2-B]- AND THIENO[3,2-B]PYRIDINE DERIVATIVES AS TBK1 AND IKKε INHIBITORS | 2013 |
|
RU2622034C2 |
CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID-DEHYDROGENASE 1 | 2009 |
|
RU2539979C2 |
Authors
Dates
2022-09-26—Published
2021-08-30—Filed